UNITAID

ACCESS SMC

Malaria Consortium

Catholic Relief Service

ACCESS-SMC continues to make major strides against malaria in Burkina Faso, Chad and Nigeria

While Africa still carries a disproportionately high burden of malaria cases there has been some improvement. Between 2010 and 2016 there was a 35 percent reduction in malaria mortality rates among children under five years old, according to the 2016 World Malaria Report. Effective antimalarial medicines, like seasonal malaria chemoprevention (SMC), are one of the major investments that have led to incidents of malaria declining.

Malaria Consortium worked to dramatically increase the number of children receiving the lifesaving intervention and achieved this after bringing together leading players in malaria prevention to deliver SMC in 2016 to over 6.4 million children in seven countries. This year, while the other four ACCESS-SMC countries implement SMC programs under Global Fund, Malaria Consortium has been supporting one last season under the ACCESS-SMC project in Burkina Faso, Chad and Nigeria.

The 2017 campaign has been successfully sustaining high coverage of SMC in all three countries. Burkina Faso and Chad reached more children than was initially targeted during the first cycle, with over 1.8 million children reached in Burkina Faso (just over 100 percent), and over 660,000 in Chad (106.6 percent). In Nigeria, 97.4 percent of the targeted 1.7 million children were administered SMC. Coverage data from second cycle in Chad and Nigeria are not available yet, but in Burkina Faso high coverage was sustained in the second and third cycle- 95.5 percent and 97.4 percent, reaching nearly 1.8 million children each cycle.

To continue this trend of reduction of malaria cases, governments and development partners need to expand SMC activities to ensure that all eligible children are treated with SMC. Despite the high coverage achieved through ACCESS-SMC, many children will still miss out on receiving SMC in 2017 due to lack of funding and production capacity for quality assured medicines used in SMC (SP+AQ). Funding is the key if countries in the Sahel are to move closer to elimination.

 

Countries

Number of districts/local government areas

Target

Cycle 1 Coverage

Burkina Faso

39

1.8 million

100.7%

Chad

14

0.6 million

106.6%

Nigeria

37

1.7 million

97.4%